Menelas Pangalos's most recent trade in Biogen Inc was a trade of 2,370 Restricted Stock Unit done . Disclosure was reported to the exchange on June 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Biogen | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 2,370 | 2,370 | - | - | Restricted Stock Unit | |
Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 57,400 | 57,400 | - | - | Stock Option (right to buy) | |
Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 14,500 | 18,175 | - | 0 | Common Stock | |
Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 15,114 | 15,114 | - | - | Stock Option (right to buy) | |
Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 3,675 | 3,675 | - | 0 | Common Stock | |
Absci Corp | Pangalos Menelas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 106,200 | 106,200 | - | - | Stock Option (right to buy) | |
Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 18,900 | 18,900 | - | - | Stock Option (right to buy) |